Schonfeld Strategic Advisors’s InflaRx IFRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,344
Closed -$25.5K 2333
2024
Q4
$25.5K Sell
10,344
-7,756
-43% -$14.9K ﹤0.01% 1893
2024
Q3
$27.7K Sell
18,100
-2,000
-10% -$3.04K ﹤0.01% 1910
2024
Q2
$35K Sell
20,100
-5,600
-22% -$8.22K ﹤0.01% 1971
2024
Q1
$39.6K Sell
25,700
-2,000
-7% -$3.27K ﹤0.01% 1907
2023
Q4
$45.2K Sell
27,700
-343,522
-93% -$589K ﹤0.01% 1674
2023
Q3
$1.11M Buy
371,222
+2,229
+0.6% +$8.48K 0.01% 987
2023
Q2
$1.65M Buy
+368,993
New +$1.65M 0.01% 811
2021
Q1
Sell
-31,300
Closed -$158K 1948
2020
Q4
$158K Sell
31,300
-177,301
-85% -$798K ﹤0.01% 1382
2020
Q3
$889K Buy
208,601
+173,361
+492% +$798K 0.02% 730
2020
Q2
$162K Buy
35,240
+13,655
+63% +$88.6K ﹤0.01% 1134
2020
Q1
$82K Buy
+21,585
New +$79.9K 0.01% 1023

Other funds holding IFRX

Schonfeld Strategic Advisors's IFRX Position: Q1 2025 in Review

Schonfeld Strategic Advisors sold out of InflaRx (IFRX) in Q1 2025, closing a stake of 10,344 shares — an estimated $25.5K sold.

Schonfeld Strategic Advisors first reported a position in IFRX in Q1 2020 and held it in 11 quarters. The position peaked at $1.65M in Q2 2023. 31 funds tracked by Wall St. Rank hold IFRX as of Q1 2025.

  • Schonfeld Strategic Advisors reported no remaining InflaRx position as of Q1 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 10,344 InflaRx shares in Q1 2025, an estimated $25.5K.
  • Schonfeld Strategic Advisors first reported a position in InflaRx in Q1 2020 and held it in 11 quarters.
  • Schonfeld Strategic Advisors's InflaRx position peaked at $1.65M in Q2 2023.
  • 31 funds tracked by Wall St. Rank held InflaRx as of Q1 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2025, filed 15 May 2025.